Prosight Management »

Pfizer shares owned by Prosight Management

Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Pfizer

Tip: Access up to 7 years of quarterly data

All positions including Pfizer held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pfizer by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.0M 215k 27.75

More positions owned by Prosight Management

Adc Therapeutics Sa SHS (ADCT)
Galapagos Nv Spon Adr (GLPG)
Bridgebio Pharma (BBIO)
Abcellera Biologics (ABCL)
Meiragtx Holdings (MGTX)
Roivant Sciences SHS (ROIV)
Shattuck Labs (STTK)
Mirum Pharmaceuticals (MIRM)
Zimmer Holdings (ZBH)
McKesson Corporation (MCK)
Kura Oncology (KURA)
Schrodinger (SDGR)
Zymeworks Del (ZYME)
Accolade (ACCD)
Dex (DXCM)

View all positions for Prosight Management

Top funds holding Pfizer

Vanguard Group
BlackRock
State Street Corporation
Wellington Management Company
Charles Schwab Investment Management
Geode Capital Management
Massachusetts Financial Services
Bank of America Corporation
Susquehanna International
State Farm Mutual Automobile Insurance Company
Northern Trust
Capital World Investors
Amundi
Legal & General Group
Citadel Advisors

View all funds holding Pfizer